Next Article in Journal
Driving Type 2 Diabetes Risk Scores into Clinical Practice: Performance Analysis in Hospital Settings
Next Article in Special Issue
Sensors for Lung Cancer Diagnosis
Previous Article in Journal
Effect of Size and Location of Nevi on Postoperative Pain and Emergence Agitation in Children Undergoing Nevi Excision
Previous Article in Special Issue
Relationship between Inflammatory and Biological Markers and Lung Cancer
Open AccessReview

Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification

Fondazione IRCCS Casa Sollievo della Sofferenza, Unit of Oncology Biomarkers, 71013 San Giovanni Rotondo (FG), Italy
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2019, 8(1), 108; https://doi.org/10.3390/jcm8010108
Received: 30 November 2018 / Revised: 10 January 2019 / Accepted: 11 January 2019 / Published: 17 January 2019
(This article belongs to the Special Issue Big Data and Precision Medicine Series I: Lung Cancer Early Diagnosis)
Recent advances in radiological imaging and genomic analysis are profoundly changing the way to manage lung cancer patients. Screening programs which couple lung cancer risk prediction models and low-dose computed tomography (LDCT) recently showed their effectiveness in the early diagnosis of lung tumors. In addition, the emerging field of radiomics is revolutionizing the approach to handle medical images, i.e., from a “simple” visual inspection to a high-throughput analysis of hundreds of quantitative features of images which can predict prognosis and therapy response. Yet, with the advent of next-generation sequencing (NGS) and the establishment of large genomic consortia, the whole mutational and transcriptomic profile of lung cancer has been unveiled and made publicly available via web services interfaces. This has tremendously accelerated the discovery of actionable mutations, as well as the identification of cancer biomarkers, which are pivotal for development of personalized targeted therapies. In this review, we will describe recent advances in cancer biomarkers discovery for early diagnosis, prognosis, and prediction of chemotherapy response. View Full-Text
Keywords: lung cancer; early diagnosis; prognosis; chemotherapy response; biomarkers; microRNA; gene expression; exosomes lung cancer; early diagnosis; prognosis; chemotherapy response; biomarkers; microRNA; gene expression; exosomes
Show Figures

Figure 1

MDPI and ACS Style

Dama, E.; Melocchi, V.; Colangelo, T.; Cuttano, R.; Bianchi, F. Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification. J. Clin. Med. 2019, 8, 108.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop